There may be a way in the future to enhance diabetes treatment—with better control of blood sugar and its use by the brain, and a lower risk for neurological problems—by attaching insulin to a specially designed nanomaterial.
Mar 29, 2022
0
17
Scientists at the Gladstone Institutes have unraveled a process by which depletion of a specific protein in the brain contributes to the memory problems associated with Alzheimer's disease. These findings provide new insights ...
Apr 26, 2012
0
0
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...
May 23, 2013
0
0
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012.
Feb 1, 2012
0
0
At this critical junction for EU chemicals legislation, the independent scientific voice took center stage at the 5th Annual Forum on Endocrine Disruptors. Together with an impressive number of concerned stakeholders, they ...
Oct 20, 2023
0
0
Many people with multiple sclerosis for years have taken the natural supplement Gingko biloba, believing it helps them with cognitive problems associated with the disease.
Sep 14, 2012
0
0
Patients with clinically diagnosed neurological symptoms associated with COVID-19 are six times more likely to die in the hospital than those without the neurological complications, according to an interim analysis from the ...
May 11, 2021
0
4
Different types of brain damage caused by a concussion may lead to similar symptoms in children, according to research led by McGill University. A new way of studying concussions could help develop future treatments.
May 17, 2022
0
56
Today's anti-depressant medications can ease depression in Parkinson's patients without worsening other symptoms of the disease, according to a study published online in Neurology, the medical journal of the American Academy ...
Apr 11, 2012
0
0
(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).
Sep 13, 2012
0
0
